Guangdonghectechnologyholdingco.Ltd(600673) released the business data announcement, the company will no longer merge pharmaceutical assets since December 29, 2021, while the company’s non pharmaceutical industry has maintained a high development boom, with booming production and sales of main products, and achieved good business results. After preliminary accounting, from January to February 2022, the company achieved an operating revenue of about 1.9 billion yuan, an increase of about 26% over the same period last year; The net profit attributable to non listed shareholders in the pharmaceutical sector increased by about 18 billion yuan over the same period last year.
The company issued a performance express on the same day. In 2021, the company achieved an operating revenue of 12.798 billion yuan, an increase of 23.40% over the previous year, and a net profit attributable to shareholders of listed companies of 860 million yuan, an increase of 106.91% over the previous year.
